Divis Laboratories Ltd - 532488 - Shareholding for the Period Ended June 30, 2019
Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here17-07-2019
17-07-2019
Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copies of notice to shareholders of the Company intimating that equity shares in respect of which dividend remain unclaimed for seven consecutive years would be transferred to Investor Education and Protection Fund (IEPF) Authority. This notice was published on 13 July 2019 in the following newspapers: Financial Express (English Daily) Andhra Prabha (Telugu Daily) This is for your information and records.13-07-2019
Divis Laboratories Ltd - 532488 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Deepa KumariDesignation :- Authorised Signatory11-07-2019
Divis Laboratories Ltd - 532488 - Closure of Trading Window
Pursuant to Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the Company from July 01, 2019 till 48 hours after the declaration of financial results for the quarter ended June 30, 2019. The date of Board Meeting for declaration of the financial results of the Company for the quarter ending on June 30, 2019 will be intimated in due course.27-06-2019
DIVI'S LABORATORIES LTD. - 532488 - US-FDA Inspection Of Unit -II At Village Chippada, Andhra Pradesh
Divi's Laboratories hereby announces that its Unit-II at village Chippada, Bheemunipatnam District, Andhra Pradesh has had an inspection by the US-FDA from 10th June 2019 to 15th June, 2019. This was a general cGMP inspection by the US-FDA. The inspection has been concluded with no 483 observations.15-06-2019
Divis Laboratories Ltd - 532488 - Submission Of Half Yearly Disclosure On Related Party Transactions
Pursuant to Regulation23(9) of SEBI (Listing Obligations and Disclosure Requirements),Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended March 31, 2019.15-06-2019
DIVI'S LABORATORIES LTD. - 532488 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report28/05/2019 3 Name of the Certifying Firm V. Bhaskara Rao & Co. 4 Name of the Certifying Individual V. Bhaskara Rao 5Membership TypeFCS 6 Membership Number 5939 7 CP No. 4182 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO28-05-2019
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company Secretary & Compliance Officer, Mrs. P. V. Lakshmi Rajani, has expressed her intention to resign due to personal reasons. Board has accepted her resignation and she ceases to be Company Secretary & Compliance Officer w.e.f close of working hours of 31st May, 2019. In the interim, in terms of Regulation 6 of the Listing Regulations, Board has designated Ms. Deepa Kumari as Compliance Officer of the Company w.e.f. 1st June, 2019. Brief profile of Ms. Deepa Kumari: Ms. Deepa Kumari is a qualified Company Secretary and has done her B.Com (Hons.) & LLB from Kolhan University. She has been with the Company for last two years in the role of Assistant Company Secretary, assisting in carrying out the secretarial matters of the Company. The Board meeting commenced at 11:00 Hrs and concluded at 14:45 Hrs25-05-2019
DIVI'S LABORATORIES LTD. - 532488 - Board recommends Dividend
Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2019, inter alia, has recommended dividend @ 800% i.e Rs. 16/- per equity share of face value Rs. 2/- each for the financial year 2018-19, subject to approval of the members at the ensuing Annual General Meeting (AGM). The dividend on Equity Shares, shall be credited/ dispatched within 30 (thirty) days from the conclusion of the AGM.25-05-2019
Divis Laboratories Ltd - 532488 - Finnacial Results For The Quarter And Year Ended 31St March 2019
Board of Directors has approved the Audited Financial Results for the quarter and year ended 31st March, 2019. Board has recommended dividend @ 800% i.e Rs. 16/- per equity share of face value Rs. 2/- each for the financial year 2018-19, subject to approval of the members at the ensuing Annual General Meeting (AGM). The dividend on Equity Shares, shall be credited/ dispatched within 30 (thirty) days from the conclusion of the AGM, the date of which will be intimated in due course.We are enclosing herewith the following: 1.Audited Standalone Financial Results for the quarter and year ended 31st March 2019. 2.Audited Consolidated Financial Results for the year ended 31st March 2019. 3.Auditors' Report on the Standalone and Consolidated Financial Results for the year. 4.Declaration regarding Audit Reports with unmodified opinion. 5.Press Release on the Financial Results of the Company The Board meeting commenced at 11:00 Hrs and concluded at 14:45 Hrs25-05-2019